Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Post Stroke Preventive Trial (PREVENT). A RCT Nested in a Cohort Study

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2009 by Hvidovre University Hospital.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Hvidovre University Hospital
ClinicalTrials.gov Identifier:
NCT00253097
First received: November 14, 2005
Last updated: August 10, 2009
Last verified: July 2009

November 14, 2005
August 10, 2009
December 2005
October 2009   (final data collection date for primary outcome measure)
blood pressure lowering at 12 and 24 months [ Time Frame: November 2006 - october 2009 ] [ Designated as safety issue: No ]
blood pressure lowering at 12 and 24 months
Complete list of historical versions of study NCT00253097 on ClinicalTrials.gov Archive Site
  • blood pressure [ Time Frame: November 2006 - october 2009 ] [ Designated as safety issue: No ]
  • BMI [ Time Frame: November 2006 - october 2009 ] [ Designated as safety issue: No ]
  • Level of physical activity [ Time Frame: November 2006 - october 2009 ] [ Designated as safety issue: No ]
  • Time to events:Stroke recurrence, MI and death [ Time Frame: November 2006 - october 2009 ] [ Designated as safety issue: No ]
  • all assessed 12 and 24 months after inclusion in the study [ Time Frame: November 2006 - october 2009 ] [ Designated as safety issue: No ]
  • Smoking cessation [ Time Frame: november 2006 to october 2009 ] [ Designated as safety issue: No ]
  • blood pressure
  • BMI
  • Smoking status
  • Level of physical activity
  • Time to events:Stroke reccurrence, MI and death
  • all assessed 12 and 24 months after inclusion in the study
Not Provided
Not Provided
 
The Post Stroke Preventive Trial (PREVENT). A RCT Nested in a Cohort Study
The Post Stroke Preventive Trial (PREVENT) A Randomised Controlled Trial Nested in a Cohort (RIALTO) Study

Patients with a diagnosis of stroke or TIA, who are already included in the RIALTO-cohort study are asked to participate in a RCT after discharge from hospital.

Patients in the intervention group will receive four visits by a study nurse with the aim of controlling the patient's hypertension, reducing risk factors like tobacco smoking and obesity, and motivating the patient to physical activity and to a healthy diet.Patients in the control group will receive the usual treatment.

This study is aimed at testing the hypothesis, that

Primary outcome: the blood pressure lowering will be greater in the intervention group Secondary outcomes: the blood pressure will be lower in the intervention group and the number of patients who have stopped smoking will be greater in the intervention group The number of obese patients who have reduced their BMI will be greater in the intervention group The number of patients with a Rankin Scale<3 who are physically active for four hours a week will be greater in the intervention group Time to recurrent stroke, MI and death will be longer in the intervention group

Outcomes are measured by follow up visit one and two years after inclusion in the study

Expected Total Enrollment: 342 in the RCT, 1200 in the cohort

Study Start: 011205 (PREVENT) Study Completion: January 2009(PREVENT), September 2013 (RIALTO Cohort study)

Stroke survivors are at risk of cerebrovascular and cardiovascular complications. In Denmark 25% of stroke admissions are caused by recurrent stroke or TIA. Little is known of the risk factors for recurrent stroke. This is being investigated in a cohort study (RIALTO) initiated in may 2004. The PREVENT study is aimed at studying the health behavior of stroke survivors as well as the effect of a preventive intervention aimed at risk factors associated with hypertension. Hypertension is the main risk factor for primary stroke and the one risk factor known to be associated with stroke recurrence.

Inclusion criteria: inclusion in the RIALTO-cohort, no severe cognitive deficits or dementia, no other life threatening disease.

Exclusion criteria: discharge to a nursing home

Participants (n=342) are randomised to either the intervention group (n=171) or the control group (n=171). Randomisation is performed by a computer-generated allocation schedule, with the randomisation sequence blocked from previewing. The analyser will be blinded from the allocation of the patients.

Baselinedata: Blood pressure, BMI and Rankin scale will be monitored few days prior to discharge.Blood pressure will be measured according to standards set by the Danish Society of hypertension.

Patients in the intervention group will receive a visit by a study nurse one, four, seven, and ten months after discharge. The aim of the visits are: controlling the patient's hypertension, reducing risk factors like tobacco smoking and obesity, motivating the patient to physical activity and to a healthy diet as well as compliance with pharmacological treatment of hypertension, diabetes, hypercholesterolemia and anti-thrombotic treatment.Patients in the control group will receive the usual treatment.

This study is aimed at testing the hypothesis, that

Primary outcome: the blood pressure lowering will be greater in the intervention group Secondary outcomes: the blood pressure will be lower in the intervention group and the number of patients who have stopped smoking will be greater in the intervention group The number of obese patients who have reduced their BMI will be greater in the intervention group The number of patients with a Rankin Scale<3 who are physically active for four hours a week will be greater in the intervention group Time to recurrent stroke, MI and death will be longer in the intervention group

Outcomes are measured by follow up visit one and two years after inclusion in the study. Hypertension is defined as a blood pressure > 140 mm Hg or > 90 mm Hg. The diagnosis of a recurrent stroke will be based on a CT og MR scan or on the clinical diagnosis made by a neurologist.MI should be confirmed by an ECG and by relevant biomarkers.

All participants will be followed up by register data for six years from inclusion as will all participants of the RIALTO cohort.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Prevention
  • Cerebrovascular Accident
  • Transient Ischemic Attack
  • Myocardial Infarction
Behavioral: Intervention
Patients allocated to the intervention group have 4 visits by a study nurse. She will measure patient's blood pressure (BP) by standardized meathods, inform the patient about the target BP, stress the importance of lowering the BP and in case of elevated BP she advices the patient to go the the GP for further control. She advises about smoking cessation, reduction of alcohol consumption, loss of excess body weigt and stresses the importance of physical activity as appropriate
  • No Intervention: Control
    Patients in the control group had the usual care provided at the stroke unit, that is counselling on avoiding risky health behavior, compliance with preventive medication, measurement of blood pressure and a 3 months' visit in the outpatient clinic
    Intervention: Behavioral: Intervention
  • Experimental: Intervention
    Patienta allocated to the intervention group have 4 visits by a study nurse. She will measure patient's blood pressure (BP) by standardized meathods, inform the patient about the target BP, stress the importance of lowering the BP and in case of elevated BP she advices the patient to go the the GP for further control. She advises about smoking cessation, reduction of alcohol consumption, loss of excess body weigt and stresses the importance of physical activity as appropriate
    Intervention: Behavioral: Intervention
Hornnes N, Larsen K, Brink-Kjær T, Boysen G. Specific antismoking advice after stroke. Dan Med J. 2014 Apr;61(4):A4816.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
353
October 2009
October 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • a diagnosis of stroke or TIA inclusion in the RIALTO cohort no severe cognitive deficits or dementia

Exclusion Criteria:

  • discharge to a nursing home
Both
15 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Denmark
 
NCT00253097
KFE 003
No
Nete Hornnes Research Director, Ph.d-student, Copenhagen University Hospital, Hvidovre
Hvidovre University Hospital
Not Provided
Study Director: Nete Hornnes, RN, MPH Clinical Research Unit, Hvidovre Hospital
Hvidovre University Hospital
July 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP